Products

InferCare RECIST
Beijing Infervision Healthcare Medical Technology Co., Ltd.
Oncology AI
An AI application designed to support tumor evaluation and tracking according to RECIST criteria, aiming to standardize tumor assessment and improve efficiency in oncology workflows.
InferOperate Suite
Beijing Infervision Healthcare Medical Technology Co.
Oncology AI
InferOperate Suite is an AI-powered medical imaging software by Infervision, offering automated 3D reconstruction, visualization, and comprehensive surgical planning tools for various procedures, including those for lung, liver, and kidney tumors.

See all 2 products →

About Beijing Infervision Healthcare Medical Technology

Beijing Infervision Healthcare Medical Technology is a leading artificial intelligence (AI) medical technology company focused on empowering physicians with enhanced diagnostic accuracy and improved clinical workflows. The company leverages deep learning and AI technologies to develop comprehensive software platforms that assist across various medical disciplines. These platforms provide advanced medical imaging analysis, aiding in the diagnosis, treatment, and management of a broad spectrum of conditions, including different types of cancers, infectious diseases, cardiovascular diseases, cerebrovascular diseases, and trauma.

Infervision’s product portfolio includes solutions for disease screening and diagnosis (e.g., InferRead® for pulmonary nodules, pneumonia, intracranial hemorrhage, coronary artery disease, and chest fractures), intervention and treatment (e.g., InferOperate® for surgical planning and 3D reconstructions for thorax, liver, and urology), patient health management (InferCare®), and teaching and research initiatives (InferScholar®, InferMartrix, InferEducate). These AI-assisted tools are designed for seamless integration into existing clinical workflows, offering real-time feedback and actionable insights. The goal is to alleviate physician workload, increase diagnostic efficiency and accuracy, and ultimately contribute to better patient outcomes and reduced healthcare costs. Infervision’s products have achieved significant international market access, holding certifications from the US FDA, European CE, Japan PMDA, UK UKCA, and China NMPA, and are utilized in hundreds of medical institutions worldwide.

Focus Areas

AI-assisted medical imaging disease screening and diagnosis intervention and treatment patient management medical research oncology pulmonary diseases cardiovascular diseases cerebrovascular diseases trauma surgical planning

Business Intelligence

Key InvestorsGoldman Sachs Asset Management, Z-Park Fund, CCB Trust, Sequoia Capital, Qiming Venture Partners, CDH Investments, Springhill Fund, AsiaTech Management, TopoScend Capital, Xianghe Capital Co., Advantech Capital LP, Genesis Capital LLC
PartnershipsGE Healthcare, ConcertAI's TeraRecon, Microsoft, NVIDIA, NHS SBS framework, Peking Union Medical College Hospital, Shanghai Changzheng Hospital, Tongji Medical College of HUST in Wuhan, Dalian Zhongshan Hospital, Beijing Tian Tan Hospital, Campus Bio-Medico University Hospital (Italy), Sanford Health
AcquisitionsNone reported.
TechnologyDeep learning, computer vision, AI-powered detection and triage systems, AI application management platform, AI data-mining research platform, AI clinical application platforms, 3D reconstruction, cloud-native/on-premise deployment options
FDA Clearances4 cleared products (estimated)

What Physicians Need to Know

AI-Assisted Medical Imaging & Diagnosis
Infervision offers a comprehensive suite of AI-powered solutions (InferReadu00ae) for rapid and accurate detection and diagnosis across various medical imaging modalities (DR, CT, MRI). This includes identifying lung nodules, pneumonia, intracranial hemorrhage, coronary artery stenosis, and chest fractures. Their AI can provide detailed nodule characteristics (volume, density) and compare with prior studies for tracking changes.
Oncology
Specialized AI tools assist in cancer screening (e.g., lung nodules), diagnosis, and patient management. Infervision's solutions aid in identifying cancerous lymph nodes, tumor assessment (InferCare RECIST), multi-dimensional lesion analysis, cross-timepoint lesion comparison, and generating automated structured reports for oncology workflows.
Pulmonary Diseases
InferReadu00ae CT Lung and DR Chest are core products for lung nodule screening, detection of pneumonia, chronic lung diseases (like emphysema), and chest fractures. The AI helps reduce missed nodules by 35% and reading times by approximately 33% for radiologists.
Cardiovascular Diseases
InferReadu00ae CT Coronary enables vessel segmentation and reconstruction, identifying coronary artery stenosis. They also offer cardiac calcification screening.
Cerebrovascular Diseases
InferReadu00ae CT Stroke provides fast identification and alerts for suspected intracranial hemorrhage (ICH) and assists in determining stroke type (hemorrhagic or ischemic), location, and blood volume, crucial for timely intervention. They have developed 5G mobile stroke units for diagnosis and treatment at the stroke site.
Trauma & Surgical Planning
InferOperateu00ae Suite offers high-precision, fully automated 3D anatomical segmentation and reconstruction within minutes for preoperative planning and intraoperative visualization. This includes planning for thorax, liver, and urology surgeries, aiding in simulating surgical strategies, quantitative lesion analysis, and precise planning of surgical margins. InferReadu00ae CT Bone assists in identifying chest fractures.
Patient Management & Medical Research
InferCareu00ae is designed for patient health management and image follow-up. InferScholaru00ae and InferMatrixu00ae are AI-enabled medical research solutions, allowing physicians with limited coding experience to conduct scientific research through deep-learning analytical tools with a graphical user interface.
Physician Tip

Infervision's AI solutions are designed to significantly enhance physician workflow by reducing reading times (e.g., 33% for CT chest low-dose lung cancer screening), improving diagnostic accuracy (e.g., reducing missed nodules by 35%), and increasing confidence in interpretations. The automated 3D reconstructions for surgical planning provide critical anatomical insights and allow for simulation of surgical strategies, potentially leading to improved patient safety and reduced complications. The systems offer real-time alerts for critical findings, enabling faster triage and intervention, especially in emergency conditions like stroke. Furthermore, their research platforms empower physicians to engage in AI-driven medical research without extensive coding knowledge.

Infervision's products are designed for seamless integration into existing clinical workflows and hospital systems. They are compatible with DICOM compliant medical images and support cross-campus oncology data management through compatibility with DICOM and HL7. Their solutions can be deployed both on-premise and cloud-based environments, offering flexibility. Partnerships with companies like Viz.ai and ConcertAI's TeraRecon further expand their integration capabilities within broader healthcare ecosystems.

Products by Beijing Infervision Healthcare Medical Technology

2 products in the directory

InferCare RECIST
Beijing Infervision Healthcare Medical Technology Co., Ltd.
Oncology AI
An AI application designed to support tumor evaluation and tracking according to RECIST criteria, aiming to standardize tumor assessment and improve efficiency in oncology workflows.
InferOperate Suite
Beijing Infervision Healthcare Medical Technology Co.
Oncology AI
InferOperate Suite is an AI-powered medical imaging software by Infervision, offering automated 3D reconstruction, visualization, and comprehensive surgical planning tools for various procedures, including those for lung, liver, and kidney tumors.

Reviews & Opinions

No web reviews on file yet for Beijing Infervision Healthcare Medical Technology. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Beijing Infervision Healthcare Medical Technology.

Loading videos...

Videos load interactively. If none appear, search YouTube for Beijing Infervision Healthcare Medical Technology →

View all on YouTube

Press & Coverage

Infervision
Infervision Receives FDA Clearance of InferOperate Suite
Infervision received FDA 510(k) clearance for its InferOperate Suite, a surgical planning AI solution, making it cleared in the US, EU, UK, and China. This suite automates 3D model generation for organs and vascular structures, aiding in preoperative planning and intraoperative guidance, particularly for high-risk tumor surgeries.
2025-09
Infervision
Leading the Future of Medical Imaging: InferVision Showcases Global-Ready AI Innovations at RSNA 2025
InferVision showcased new breakthroughs in surgical planning, oncology assessment, and global ecosystem collaboration at RSNA 2025, reaffirming its leadership in AI healthcare. Their InferOperate automatic 3D reconstruction products have achieved regulatory milestones with CE, UKCA, and FDA clearances, enabling full-scale commercial deployment.
2025-12
Infervision
Infervision Receives FDA 510(k) Clearance for Enhanced Features in InferRead CT Lung
Infervision announced FDA 510(k) clearance for enhanced features in its InferReadu00ae Lung CT.AI product, strengthening its position in AI-driven lung nodule detection. This clearance, alongside approvals from European CE, UK UKCA, Japan PMDA, and China NMPA, expands Infervision's global regulatory footprint.
2025-05
Infervision
Infervision's AI Solutions for Chest, Brain, and Heart Secure CE and UKCA Certifications
Infervision's AI-assisted diagnostic solutions for chest, brain, and heart have received dual certification from European MDR CE and UKCA, strengthening its presence in European and UK markets. These certifications cover indications for pulmonary nodules, pneumonia, intracranial hemorrhage, coronary artery disease, and chest fractures.
2024-08
Infervision
Viz.ai and Infervision Partner on AI Solution to Aid in Earlier Detection and Clinical Workup of Lung Cancer
Viz.ai announced a partnership with Infervision to incorporate InferRead Lung CT.AI, Infervision's FDA-cleared AI solution for lung nodule detection, into the Viz.ai ecosystem. This collaboration aims to improve the earlier detection and clinical workup of lung cancer.
2024-04
AuntMinnie
SimonMed to integrate Infervision tech into its facilities
SimonMed Imaging is integrating Infervision's AI-powered InferRead Lung CT.AI technology into its facilities to enhance the identification, 3D characterization, and comparison of pulmonary nodules in CT chest scans.
2024-04
PR Newswire
InferVision Completes Series D2 Financing Round Led by Goldman Sachs Asset Management
InferVision, an AI medical provider, completed its Series D2 financing round led by Goldman Sachs Asset Management, raising approximately US$140 million in total from Series D1 and D2. The funds will be used for R&D, distribution channel expansion, and business development.
2021-08
KrASIA
AI medtech startup InferVision raises USD 139 million in Series D for predictive medicine
Beijing-based medical AI company InferVision completed a Series D round worth RMB 900 million (USD 139 million) from investors including Goldman Sachs, Z-Park Fund, and CCB Trust. The funds will be allocated to research and development and expanding into new overseas markets.
2021-07

Frequently Asked Questions

Infervision's InferReadu00ae product series provides AI-assisted diagnostic solutions for a wide range of conditions, including pulmonary nodules, pneumonia, intracranial hemorrhage (stroke), coronary artery disease, and chest fractures. These solutions aim to enhance diagnostic accuracy and efficiency, covering oncology, pulmonary, cardiovascular, cerebrovascular, and trauma specialties.
Infervision offers the InferOperateu00ae Suite, an AI-powered solution for intervention and treatment, specifically surgical planning. This suite automates high-precision 3D anatomical segmentation and reconstruction within minutes, aiding in preoperative planning and intraoperative visualization for complex procedures involving organs like the lungs, liver, and kidneys.
Infervision's AI solutions have secured multiple international regulatory approvals, including certifications from the US FDA, European MDR CE, UKCA, Japan PMDA, and China NMPA. This broad compliance ensures their products meet stringent quality and safety standards for deployment in major global markets.
Infervision extends its AI capabilities to patient health management through InferCareu00ae, and supports medical research and education with InferScholaru00ae, InferMartrix, and InferEducate. For instance, InferCare RECIST provides AI-powered, standardized tumor assessment for oncology workflows and follow-up.
Infervision has formed strategic partnerships to integrate its AI solutions, such as collaborating with Viz.ai to incorporate InferRead Lung CT.AI into their care coordination platform. They also partner with ConcertAI's TeraRecon to make their lung CT AI available on the Eureka Clinical AI platform, and their solutions are included in frameworks like the UK's National Health Service (NHS).
Established in 2016, Infervision is a Series D company with over $213 million in funding, indicating strong financial stability. The company has a global presence with offices in the US, Europe, and Japan, and its products are used by over 900 healthcare providers in nearly 20 countries, suggesting a robust infrastructure for long-term support.
Infervision offers various pricing options designed to meet diverse needs, though specific models are not publicly detailed. The company emphasizes developing 'workflow friendly' and accurate solutions, suggesting a focus on seamless integration and efficiency for clinicians, with support aimed at improving diagnostic accuracy and reducing reading times.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.